ConductScience.org, home

Paper286331

Amidolytic properties of single-chain activated Hageman factor.

Ratnoff OD and 1 other. Proc Natl Acad Sci U S A, 1979. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Amidolytic properties of single-chain activated Hageman factor. Papers, record 286331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/286331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amidolytic properties of single-chain activated Hageman factor.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ratnoff ODO D
2Saito HH

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmidohydrolasesMajor topic
Factor XIIMajor topic
Antigen-Antibody Reactions
Enzyme Activation
Humans
Immune Sera
Molecular Weight
Oxidation-Reduction

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1284420Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/284420PubMed
2632748Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.J Exp Med1978https://conductscience.org/library/papers/632748PubMed
3864009
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
J Clin Invest1977https://conductscience.org/library/papers/864009PubMed
4893664Purification of high molecular weight kininogen and the role of this agent in blood coagulation.J Clin Invest1977https://conductscience.org/library/papers/893664PubMed
5901768Characterization of bovine factor XIIa (activated Hageman factor).Biochemistry1977https://conductscience.org/library/papers/901768PubMed
6866349Detection by fluorescence of structural changes accompanying the activation of Hageman factor (factor XII).Proc Soc Exp Biol Med1977https://conductscience.org/library/papers/866349PubMed
74856788Inhibition of normal clotting and Fletcher factor activity by rabbit anti-kallikrein antiserum.Nature1974https://conductscience.org/library/papers/4856788PubMed
84277669Structural changes accompanying enzymatic activation of human Hageman factor.J Clin Invest1974https://conductscience.org/library/papers/4277669PubMed
94271629Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.J Exp Med1973https://conductscience.org/library/papers/4271629PubMed
104858003Inhibition of the adsorption of Hagemen factor (Factor XII) to glass by normal human plasma.J Lab Clin Med1974https://conductscience.org/library/papers/4858003PubMed
114106492The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).J Exp Med1971https://conductscience.org/library/papers/4106492PubMed
124373492The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents.J Clin Invest1974https://conductscience.org/library/papers/4373492PubMed
134826936Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.Circ Res1974https://conductscience.org/library/papers/4826936PubMed
144673237Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).J Lab Clin Med1972https://conductscience.org/library/papers/4673237PubMed
155131637The kinin system of human plasma. V. The probable derivation of prekallikrein activator from activated Hageman factor (XIIa).Proc Soc Exp Biol Med1971https://conductscience.org/library/papers/5131637PubMed
165543879
Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.
J Clin Invest1971https://conductscience.org/library/papers/5543879PubMed
175806584The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.J Biol Chem1969https://conductscience.org/library/papers/5806584PubMed
186075445Experiments on the nature of the prothrombin-converting principle: alteration of proaccelerin by thrombin.Br J Haematol1967https://conductscience.org/library/papers/6075445PubMed
195844078Hageman factor: alterations in physical properties during activation.Science1965https://conductscience.org/library/papers/5844078PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
33107140Proteolytic activity of contact factor zymogens.J Thromb Haemost2021https://conductscience.org/library/papers/33107140PubMed
31800958Protease activity in single-chain prekallikrein.Blood2020https://conductscience.org/library/papers/31800958PubMed
28604413Single-chain factor XII: a new form of activated factor XII.Curr Opin Hematol2017https://conductscience.org/library/papers/28604413PubMed
28069606Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.Blood2017https://conductscience.org/library/papers/28069606PubMed
6793628Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.J Clin Invest1981https://conductscience.org/library/papers/6793628PubMed
3722381High molecular weight kininogen binds to unstimulated platelets.J Clin Invest1986https://conductscience.org/library/papers/3722381PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F122161PubTator's text mininghttps://conductscience.org/library/genes/2161

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/286331

GET https://conductscience.org/api/papers/v1/286331/authors